| Pharmacokinetics in pregnancy; clinical significance. | |
| | |
MedLine Citation:
|
PMID: 22113390 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
In pharmacokinetics drug absorption, distribution, clearance, and bioequivalence are usually considered, but during pregnancy the most important variable is adherence or compliance. Pharmacokinetic changes during pregnancy that may lead to changes in maternal drug use are described through presentation of cases highlighting the relevance of these changes. Non-invasive methods of pharmacokinetic analysis, such as determining concentrations of drug in hair, are now being tested and used.Pharmacokinetics are important, but one needs to consider the entire pregnant state and its circumstances when treating women. One treats people, not a "volume of distribution" or a drug level. Therapy should be individualized as much as possible, addressing kinetic changes in the context of dynamic alterations and the effects of underlying medical conditions. To ensure that women are not orphaned from advances in drug therapy, much more research is needed into the determinants of pharmacokinetic and pharmacodynamic changes in pregnancy. |
| | |
Authors:
|
Gideon Koren |
Publication Detail:
|
Type: Journal Article Date: 2011-11-14 |
Journal Detail:
|
Title: Journal of population therapeutics and clinical pharmacology = Journal de la thérapeutique des populations et de la pharamcologie clinique Volume: 18 ISSN: 1710-6222 ISO Abbreviation: J Popul Ther Clin Pharmacol Publication Date: 2011 |
Date Detail:
|
Created Date: 2011-11-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101530023 Medline TA: J Popul Ther Clin Pharmacol Country: Canada |
Other Details:
|
Languages: eng Pagination: e523-7 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: [Multi-Dose Packaging of Drugs as the Causative Vehicle for Multidrug-Resistant Enterobacter cloacae...
Next Document: Hypomagnesaemia and targeted anti-epidermal growth factor receptor (EGFR) agents.